Maternal immunization: opportunities for scientific advancement

Clin Infect Dis. 2014 Dec 15;59 Suppl 7(Suppl 7):S408-14. doi: 10.1093/cid/ciu708.


Maternal immunization is an effective strategy to prevent and/or minimize the severity of infectious diseases in pregnant women and their infants. Based on the success of vaccination programs to prevent maternal and neonatal tetanus, maternal immunization has been well received in the United States and globally as a promising strategy for the prevention of other vaccine-preventable diseases that threaten pregnant women and infants, such as influenza and pertussis. Given the promise for reducing the burden of infectious conditions of perinatal significance through the development of vaccines against relevant pathogens, the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) sponsored a series of meetings to foster progress toward clinical development of vaccines for use in pregnancy. A multidisciplinary group of stakeholders convened at the NIH in December 2013 to identify potential barriers and opportunities for scientific advancement in maternal immunization.

Keywords: immunization; maternal; pregnancy; research; vaccines.

MeSH terms

  • Clinical Trials as Topic
  • Communicable Disease Control*
  • Female
  • Humans
  • Immunity, Maternally-Acquired
  • Immunization Programs
  • Immunization*
  • Infant
  • Influenza Vaccines
  • Influenza, Human / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious / prevention & control*
  • Tetanus / prevention & control
  • United States
  • Vaccines* / administration & dosage
  • Vaccines* / adverse effects
  • Vaccines* / immunology
  • Whooping Cough / prevention & control


  • Influenza Vaccines
  • Vaccines